Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The early cancer is detected, the easier it is to treat.
People with both obesity and liver steatosis were at greater risk for hospitalization with COVID-19.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
However, people with cirrhosis alone were as likely to die as those with both cirrhosis and COVID-19.
This finding comes from data on COVID-19 cases diagnosed in people with chronic liver disease and reported to international registries.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.